Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H19N3O5S.3H2O |
Molecular Weight | 419.45 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(O)=O
InChI
InChIKey=MQXQVCLAUDMCEF-CWLIKTDRSA-N
InChI=1S/C16H19N3O5S.3H2O/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7;;;/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24);3*1H2/t9-,10-,11+,14-;;;/m1.../s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A02BD06
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
A02BD07
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QA02BD07
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.1 (AMO/CLA)
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
J01CR02
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QA02BD01
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
NCI_THESAURUS |
C1500
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88E
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QA02BD04
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88B
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
A02BD03
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 526.88
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QA02BD05
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QJ01CA04
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
A02BD10
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.1
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88H
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
A02BD05
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
J01CA04
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QJ01CR02
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88C
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
A02BD04
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
NDF-RT |
N0000175497
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
A02BD11
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88F
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QG51AA03
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QA02BD03
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88A
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
LIVERTOX |
NBK547854
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88G
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QA02BD06
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-VATC |
QJ51CR02
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 556.38
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 522.88
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
WHO-ATC |
A02BD01
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
||
|
CFR |
21 CFR 520.88D
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
723
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
ALTERNATIVE | |||
|
51254
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
D000658
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
100000092629
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
Amoxicillin and Clavulanic Acid
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
Amoxicillin
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
DB01060
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
1031503
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
DTXSID2022599
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
804826J2HU
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
CHEMBL1082
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
C237
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
m1844
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | Merck Index | ||
|
AMOXICILLIN
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless. Solubility: Slightly soluble in water and methanol R; very slightly soluble in ethanol (~750 g/l) TS, ether R, and fatty oils; soluble in dilute acids and dilute solutions of alkali hydroxides. Category: Antibacterial drug. Storage: Amoxicillin trihydrate should be kept in a tightly closed container. Requirement: Amoxicillin trihydrate contains not less than 95.0% and not more than the equivalent of 102.0% of C16H19N3O5S, calculated with reference to the anhydrous substance. | ||
|
61336-70-7
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
804826J2HU
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
SUB00504MIG
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
AMOXICILLIN
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
62883
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
133008
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
192
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY | |||
|
2676
Created by
admin on Fri Dec 15 16:19:41 UTC 2023 , Edited by admin on Fri Dec 15 16:19:41 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD